AS

Amit Sharma

Active Director Director DIN 08969189
DIN 08969189 First appointment Nov 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Amit Sharma

Data last updated:

Amit Sharma is a Director at Eldecock Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Eldecock Pharmaceuticals Private Limited reported revenue of ₹21,000 (FY 2022).

DIN 08969189
Primary Designation Director
Industry Chemicals
First Appointment 27 Nov 2020
Oldest Company Age 5 yrs
Largest company Eldecock Pharmaceuticals Private Limited · ₹21,000 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Nov 20202020₹21,000 (FY 2022)Active

Board colleagues of Amit Sharma

NameDINCompanyDesignation
Deep Mala Sharma08966924Eldecock Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Eldecock Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amit Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Sharma

Amit Sharma currently holds 1 directorship: Eldecock Pharmaceuticals Private Limited (Director, since 27 Nov 2020, revenue ₹21,000 (FY 2022)).

Amit Sharma was first appointed on 27 Nov 2020 as Director at Eldecock Pharmaceuticals Private Limited.

The current boards of Amit Sharma's companies include Deep Mala Sharma (Eldecock Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available